Bioelectronics Corp (BIEL)

[srinsocal]

Thanks Hawk and GG, That 150 patient C-Section Study will garner much more attention due to its size.

A randomized, controlled, double-blinded study that investigated the effectiveness of RecoveryRx in treating postoperative pain in 150 woman who underwent cesarean section surgery. These women presented with the following average baseline demographics: 27.1 years of age, gestation period of 38.7 weeks and 2 prior cesarean section surgeries. The primary outcome measure was differences in postoperative pain as assessed on a 0-10 visual analog scale. The results indicate that the effect of active treatment with RecoveryRx provides a statistically significant treatment effect (reduction in postoperative pain), when compared to placebo (p<0.05). Manuscript under peer-review for publication.